Basic Information
| RNALocate ID: | RLID:01001426 |
| RNA Symbol: | hsa-miR-99a-5p |
| Localization: | Cytoplasm |
RNA Information
| RNA Name: | hsa-miR-99a |
| RNA ID: | miRBase:MIMAT0000097 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 24918059 |
| Tissue/Cell Line: | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) |
| Method: | Microarray |
| Description: | Data are collected from supplementary Table S2. MiRNA reads in the subcellular fractions. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001425 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001427 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001428 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001429 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001430 | Nucleolus | Breast adenocarcinoma cells (MCF-7) | 24918059 |
| RLID:11000987 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000988 | Exosome | Human cervical cancer cell line (HeLa) | 25760330 |
| RLID:11000989 | Exosome | Primary dendritic cells | 21505438 |
| RLID:11000990 | Exosome | Plasma | 23663360 |
| RLID:11000991 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000992 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000031 | Exosome | Blood|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Seminal fluid | |
| RLID-D:11000296 | Microvesicle | Blood|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-99a-5p | Diffuse large b cell lymphoma | MNDR-E-MI-73041 |
| MNDR | hsa-miR-99a-5p | Splenic marginal zone lymphoma | MNDR-E-MI-73042 |
| MNDR | hsa-miR-99a-5p | Oral squamous cell carcinoma | MNDR-E-MI-73043 |
| MNDR | hsa-miR-99a-5p | Large cell neuroendocrine cancer | MNDR-E-MI-73044 |
| MNDR | hsa-miR-99a-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-73045 |
| MNDR | hsa-miR-99a-5p | Ovarian clear cell carcinoma | MNDR-E-MI-73046 |
| MNDR | hsa-miR-99a-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-73047 |
| MNDR | hsa-miR-99a-5p | Lymphoma | MNDR-E-MI-73048 |
| MNDR | hsa-miR-99a-5p | Lymphoma non-hodgkin | MNDR-E-MI-73049 |
| MNDR | hsa-miR-99a-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-73050 |
| MNDR | hsa-miR-99a-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-73051 |
| MNDR | hsa-miR-99a-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-73052 |
| MNDR | hsa-miR-99a-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-73053 |
| MNDR | hsa-miR-99a-5p | Her2-receptor positive breast cancer | MNDR-E-MI-73054 |
| MNDR | hsa-miR-99a-5p | Breast cancer luminal | MNDR-E-MI-73055 |
| MNDR | hsa-miR-99a-5p | Niemann-pick disease type c | MNDR-E-MI-73056 |
| MNDR | hsa-miR-99a-5p | Dermatomyositis | MNDR-E-MI-73057 |
| MNDR | hsa-miR-99a-5p | Prostate cancer | MNDR-E-MI-73058 |
| MNDR | hsa-miR-99a-5p | Gastric cancer | MNDR-E-MI-73059 |
| MNDR | hsa-miR-99a-5p | Gastric lymphoma | MNDR-E-MI-73060 |
| MNDR | hsa-miR-99a-5p | Alzheimer disease | MNDR-E-MI-73061 |
| MNDR | hsa-miR-99a-5p | Intracranial aneurysm | MNDR-E-MI-73062 |
| MNDR | hsa-miR-99a-5p | Bladder cancer | MNDR-E-MI-73063 |
| MNDR | hsa-miR-99a-5p | Esophageal carcinoma | MNDR-E-MI-73064 |
| MNDR | hsa-miR-99a-5p | Dysautonomia familial | MNDR-E-MI-73065 |
| MNDR | hsa-miR-99a-5p | Seizures | MNDR-E-MI-73066 |
| MNDR | hsa-miR-99a-5p | Head and neck cancer | MNDR-E-MI-73067 |
| MNDR | hsa-miR-99a-5p | Leukemia | MNDR-E-MI-73068 |
| MNDR | hsa-miR-99a-5p | Ataxia telangiectasia | MNDR-E-MI-73069 |
| MNDR | hsa-miR-99a-5p | Cardiovascular disease | MNDR-E-MI-73070 |
| MNDR | hsa-miR-99a-5p | Lung cancer | MNDR-E-MI-73071 |
| MNDR | hsa-miR-99a-5p | Down syndrome | MNDR-E-MI-73072 |
| MNDR | hsa-miR-99a-5p | Parkinson disease | MNDR-E-MI-73073 |
| MNDR | hsa-miR-99a-5p | Niemann-pick disease | MNDR-E-MI-73074 |
| MNDR | hsa-miR-99a-5p | Basal-like breast cancer | MNDR-E-MI-73075 |
| MNDR | hsa-miR-99a-5p | Neuroendocrine neoplasia | MNDR-E-MI-73076 |
| MNDR | hsa-miR-99a-5p | Pancreatic cancer | MNDR-E-MI-73077 |
| MNDR | hsa-miR-99a-5p | Melanoma | MNDR-E-MI-73078 |
| MNDR | hsa-miR-99a-5p | Lesch-nyhan syndrome | MNDR-E-MI-73079 |
| MNDR | hsa-miR-99a-5p | Hepatitis B | MNDR-E-MI-73080 |
| MNDR | hsa-miR-99a-5p | Colon cancer | MNDR-E-MI-73081 |
| MNDR | hsa-miR-99a-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-73082 |
| MNDR | hsa-miR-99a-5p | Ovarian cancer | MNDR-E-MI-73083 |
| MNDR | hsa-miR-99a-5p | Prostate adenocarcinoma | MNDR-E-MI-73084 |
| MNDR | hsa-miR-99a-5p | Carcinoma ductal breast | MNDR-E-MI-73085 |
| MNDR | hsa-miR-99a-5p | Glioblastoma | MNDR-E-MI-73086 |
| MNDR | hsa-miR-99a-5p | Glioma | MNDR-E-MI-73087 |
| MNDR | hsa-miR-99a-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-73088 |
| MNDR | hsa-miR-99a-5p | Chordoma | MNDR-E-MI-73089 |
| MNDR | hsa-miR-99a-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-73090 |
| MNDR | hsa-miR-99a-5p | Epilepsy temporal lobe | MNDR-E-MI-73091 |
| MNDR | hsa-miR-99a-5p | Osteosarcoma | MNDR-E-MI-73092 |
| MNDR | hsa-miR-99a-5p | Inclusion body myositis | MNDR-E-MI-73093 |
| MNDR | hsa-miR-99a-5p | Breast carcinoma | MNDR-E-MI-73094 |
| MNDR | hsa-miR-99a-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-73095 |
| MNDR | hsa-miR-99a-5p | Meningioma | MNDR-E-MI-73096 |
| MNDR | hsa-miR-99a-5p | Uterine cancer | MNDR-E-MI-73097 |
| MNDR | hsa-miR-99a-5p | Cervical adenocarcinoma | MNDR-E-MI-73098 |
| MNDR | hsa-miR-99a-5p | Gastric adenocarcinoma | MNDR-E-MI-73099 |
| MNDR | hsa-miR-99a-5p | Cervical squamous cell carcinoma | MNDR-E-MI-73100 |
| MNDR | hsa-miR-99a-5p | Lung squamous cell carcinoma | MNDR-E-MI-73101 |
| MNDR | hsa-miR-99a-5p | Lung adenocarcinoma | MNDR-E-MI-73102 |
| MNDR | hsa-miR-99a-5p | Adrenocortical cancer | MNDR-E-MI-73103 |
| MNDR | hsa-miR-99a-5p | Thyroid carcinoma | MNDR-E-MI-73104 |
| MNDR | hsa-miR-99a-5p | Ovarian carcinoma | MNDR-E-MI-73105 |
| MNDR | hsa-miR-99a-5p | Bladder urothelial carcinoma | MNDR-E-MI-73106 |
| MNDR | hsa-miR-99a-5p | Pancreatic adenocarcinoma | MNDR-E-MI-73107 |
| MNDR | hsa-miR-99a-5p | Brain stem cancer | MNDR-E-MI-73108 |
| MNDR | hsa-miR-99a-5p | Carcinoma renal cell | MNDR-E-MI-73109 |
| MNDR | hsa-miR-99a-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-73110 |
| MNDR | hsa-miR-99a-5p | Clear cell renal cell carcinoma | MNDR-E-MI-73111 |
| MNDR | hsa-miR-99a-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-73112 |
| MNDR | hsa-miR-99a-5p | Cholangiocarcinoma | MNDR-E-MI-73113 |
| MNDR | hsa-miR-99a-5p | Esophageal cancer | MNDR-E-MI-73114 |
| MNDR | hsa-miR-99a-5p | Liver cirrhosis | MNDR-E-MI-73115 |
| MNDR | hsa-miR-99a-5p | Lung small cell carcinoma | MNDR-E-MI-73116 |
| MNDR | hsa-miR-99a-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-73117 |
| MNDR | hsa-miR-99a-5p | T acute lymphoblastic leukemia | MNDR-E-MI-73118 |
| MNDR | hsa-miR-99a-5p | Acute t cell leukemia | MNDR-E-MI-73119 |
| MNDR | hsa-miR-99a-5p | Breast invasive carcinoma | MNDR-E-MI-73120 |
| MNDR | hsa-miR-99a-5p | Early hepatocellular carcinoma | MNDR-E-MI-73121 |
| MNDR | hsa-miR-99a-5p | B-cell lymphoma | MNDR-E-MI-73122 |
| MNDR | hsa-miR-99a-5p | Rheumatoid arthritis | MNDR-E-MI-73123 |
| MNDR | hsa-miR-99a-5p | T-cell leukemia | MNDR-E-MI-73124 |
| MNDR | hsa-miR-99a-5p | Neuroblastoma | MNDR-E-MI-73125 |
| MNDR | hsa-miR-99a-5p | Barrett's adenocarcinoma | MNDR-E-MI-73126 |
| MNDR | hsa-miR-99a-5p | Hodgkin lymphoma | MNDR-E-MI-73127 |
| MNDR | hsa-miR-99a-5p | Burkitt lymphoma | MNDR-E-MI-73128 |
| MNDR | hsa-miR-99a-5p | Psoriasis | MNDR-E-MI-73129 |
| MNDR | hsa-miR-99a-5p | Acute myelocytic leukemia | MNDR-E-MI-73130 |
| MNDR | hsa-miR-99a-5p | Colorectal cancer | MNDR-E-MI-73131 |
| MNDR | hsa-miR-99a-5p | Nasopharynx carcinoma | MNDR-E-MI-73132 |
| MNDR | hsa-miR-99a-5p | Multiple myeloma | MNDR-E-MI-73133 |
| MNDR | hsa-miR-99a-5p | Ovarian epithelial cancer | MNDR-E-MI-73134 |
| MNDR | hsa-miR-99a-5p | Esophageal squamous cell carcinoma | MNDR-E-MI-73135 |
| MNDR | hsa-miR-99a-5p | Nasopharyngeal cancer | MNDR-E-MI-73136 |
| MNDR | hsa-miR-99a-5p | Sleep deprivation | MNDR-E-MI-73137 |
| MNDR | hsa-miR-99a-5p | Epstein-barr virus infections | MNDR-E-MI-73138 |
| MNDR | hsa-miR-99a-5p | Cerebral hemorrhage traumatic | MNDR-E-MI-73139 |
| MNDR | hsa-miR-99a-5p | Intracranial hemorrhage hypertensive | MNDR-E-MI-73140 |
| MNDR | hsa-miR-99a-5p | Pancreatitis chronic | MNDR-E-MI-73141 |
| MNDR | hsa-miR-99a-5p | Stroke lacunar | MNDR-E-MI-73142 |
| MNDR | hsa-miR-99a-5p | Barrett's carcinogenesis | MNDR-E-MI-73143 |
| MNDR | hsa-miR-99a-5p | Breast cancer her3+ negative | MNDR-E-MI-73144 |
| MNDR | hsa-miR-99a-5p | Duke C | MNDR-E-MI-73145 |
| MNDR | hsa-miR-99a-5p | High grade dysplastic nodule | MNDR-E-MI-73146 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | AGO2 | Homo sapiens | RR00055719 |
TOP